Healthcare & Life Sciences
GondolaBio
United Statesgondolabio.com
GondolaBio is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
2024
Founded
1
Investors
About GondolaBio
Based in the United States, GondolaBio is a startup founded in 2024. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
GondolaBio is a clinical-stage biopharmaceutical company developing oral small molecule therapeutics targeting rare genetic diseases, including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), aiming to create disease-modifying treatments.
Explore GondolaBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.